Children's Oncology Group: all 447 studies

Page 3 of 5. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.

• Studying Chromosomes in Samples From Younger Patients With NeuroblastomaCompletedNCT01589341
• Studying Gene Expression and Location in Samples From Patients With Brain TumorsCompletedNCT01585389
• Studying Genes in Samples From Younger Patients With RhabdomyosarcomaCompletedNCT01585376
• Studying Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01581528
• Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms TumorCompletedNCT01576211
• Studying Biomarkers in Samples From Younger Patients With Wilms TumorCompletedNCT01576198
• Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid LeukemiaCompletedNCT01576185
• Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal TumorsCompletedNCT01572467
• Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
• Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their ParentsCompletedNCT01556256Not applicable
• Studying Gene Expression in Samples From Younger Patients With NeuroblastomaCompletedNCT01553448
• Studying Gene Expression in Samples From Patients With Rhabdoid TumorsCompletedNCT01553175
• Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic LeukemiaCompletedNCT01553162
• Biomarkers in Urine Samples From Patients With Wilms TumorCompletedNCT01550393
• Studying Biomarkers in Samples From Young Patients With Rhabdoid TumorsCompletedNCT01544569
• Studying Biomarkers in Samples From Younger Patients With Wilms TumorCompletedNCT01542333
• Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01540578
• Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic LeukemiaCompletedNCT01533168
• Studying Genes in Samples From Younger Patients With Adrenocortical TumorCompletedNCT01528956
• Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01520246
• Gene Expression in Predicting Outcome in Samples From Patients With High-Risk NeuroblastomaCompletedNCT01520233
• Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative DisorderCompletedNCT01511575
• Studying Biomarkers in Samples From Patients With High-Risk NeuroblastomaCompletedNCT01510600
• Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical TrialCompletedNCT01507441
• Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionCompletedNCT01503632Phase 3
• Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01500499
• Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01498302
• Biomarkers in Tumor Tissue Samples From Younger Patients With RhabdomyosarcomaCompletedNCT01496573
• Biomarkers in Tumor Samples From Younger Patients With NeuroblastomaCompletedNCT01493830
• Biomarkers in Samples From Younger Patients With Wilms TumorCompletedNCT01493817
• Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin LymphomaCompletedNCT01490801
• Biomarkers in Tissue Samples From Patients With Ewing SarcomaCompletedNCT01480518
• Biomarkers in Patients With RhabdomyosarcomaCompletedNCT01466283
• Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid TumorWithdrawnNCT01453465
• Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid LeukemiaCompletedNCT01438138
• DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT01434355
• Studying Biomarkers in Samples From Patients With RhabdomyosarcomaCompletedNCT01433237
• Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor ProgressionCompletedNCT01433224
• Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1CompletedNCT01430637
• Protein Expression in Samples From Young Patients With RhabdomyosarcomaCompletedNCT01426945
• DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With RhabdomyosarcomaCompletedNCT01419509
• Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01419496
• Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531CompletedNCT01407757
• Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 TrialCompletedNCT01407744
• Protein Expression in Human Neuroblastoma Tumor SamplesCompletedNCT01407731
• Cell Samples From Patients With LeukemiaCompletedNCT01395628
• Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed NeuroblastomaCompletedNCT01387724
• Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With OsteosarcomaCompletedNCT01374672
• Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell LymphomaCompletedNCT01366170
• Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin LymphomaCompletedNCT01366157
• Biomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaCompletedNCT01365962
• Biomarker in Tissue Samples From Patients With Ewing SarcomaCompletedNCT01365949
• Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With NeuroblastomaCompletedNCT01358617
• Biomarkers in Samples From Young Patients With NeuroblastomaCompletedNCT01358604
• Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing CancerCompletedNCT01353300
• Biomarkers in Samples From Young Patients With Soft Tissue SarcomaCompletedNCT01342783
• Biomarkers in Tissue Samples From Young Patients With Liver CancerCompletedNCT01336881
• Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01321385
• Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms TumorCompletedNCT01314391
• Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01298414
• Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01295476
• Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid LeukemiaCompletedNCT01290107
• Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaCompletedNCT01273090Phase 1
• Biomarkers in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01247584
• Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01245231
• Biomarkers in Tissue Samples From Patients With Acute Promyelocytic LeukemiaCompletedNCT01232855
• Biomarker Study in Tissue Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01232842
• Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaCompletedNCT01230983Phase 3
• Biomarkers in Tissue Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01229956
• RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid LeukemiaCompletedNCT01229124
• Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALLCompletedNCT01225874Not applicable
• DNA Biomarkers in Tissue Samples From Patients With OsteosarcomaCompletedNCT01190943
• Biomarkers in Young Patients With NeuroblastomaCompletedNCT01169376
• INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseCompletedNCT01164163Phase 1
• Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With LeukemiaCompletedNCT01150669
• Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01150656
• Drug Biomarkers in Cell Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01150058
• Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic LeukemiaCompletedNCT01146223
• Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01146210
• Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01142427
• DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy VolunteersCompletedNCT01139983
• Biomarker Changes in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01139931
• Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01139333
• Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab OzogamicinCompletedNCT01139320
• Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic LeukemiaCompletedNCT01139307
• Biomarkers in Young Patients With Acute Myeloid LeukemiaCompletedNCT01138332
• Biomarkers in Patients With Acute Myeloid LeukemiaCompletedNCT01138319
• Biomarkers in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01138306
• Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic LeukemiaCompletedNCT01119586
• Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])CompletedNCT01119560
• Biomarkers in Tissue Samples From Patients With High-Risk Wilms TumorCompletedNCT01118078
• Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology GroupActive, not recruitingNCT01117168
• Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid LeukemiaCompletedNCT01076569
• Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic OsteosarcomaCompletedNCT01062438
• Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01057303
• Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01057290
• Studying Biomarkers in Cell Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01057199
• Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01057095
• Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesCompletedNCT01048892Phase 1
• Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421CompletedNCT01035307

← Children's Oncology Group overview and focus areas